Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myopic Choroidal Neovascularization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03070717
What this trial is testing

High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)

Who this might be right for
Pathologic Myopia
Novartis Pharmaceuticals 153
Post-approval studies (Phase 4)Study completedNCT00797992
What this trial is testing

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal Neovascularization
Instituto de Olhos de Goiania 5
Very early researchStudy completedNCT06879301
What this trial is testing

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

Who this might be right for
Diabetic Macular Edema (DME)Retinal Vein Occlusion (RVO)Myopic Choroidal Neovascularisation
Tanta University 60
Post-approval studies (Phase 4)Study completedNCT03042871
What this trial is testing

Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Zhongshan Ophthalmic Center, Sun Yat-sen University 54
Not applicableNot Yet RecruitingNCT06918028
What this trial is testing

An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings

Who this might be right for
Retinal DiseasesChoroidal DiseasePathological Myopia+3 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 9,999
Not applicableActive Not RecruitingNCT06527274
What this trial is testing

Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization

Who this might be right for
Nearsightedness
Université de Montréal 25
Post-approval studies (Phase 4)UnknownNCT01246089
What this trial is testing

Ranibizumab for Myopic Neovascularization

Who this might be right for
Myopic Choroidal Neovascularization
Instituto de Olhos de Goiania 20
Testing effectiveness (Phase 2)Study completedNCT01037348
What this trial is testing

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

Who this might be right for
Choroidal Neovascularisation
Novartis 65
Not applicableUnknownNCT03797547
What this trial is testing

Real Life Study in Myopic Neovascularization

Who this might be right for
Myopic Choroidal Neovascularisation
Poitiers University Hospital 24
Not applicableUnknownNCT04488887
What this trial is testing

OCTA Metrics Repeatability and Reproducibility in Different Disorders

Who this might be right for
Diabetic RetinopathyMyopiaChoroidal Neovascularization+1 more
Tanta University 80
Not applicableWithdrawnNCT01218230
What this trial is testing

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Who this might be right for
Myopic Choroidal Neovascular Membrane
L.V. Prasad Eye Institute
Large-scale testing (Phase 3)Study completedNCT00967850
What this trial is testing

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

Who this might be right for
MyopiaChoroidal Neovascularization
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 56
Early research (Phase 1)Temporarily pausedNCT04222842
What this trial is testing

CM082 in Patients With Myopic Choroidal Neovascularization (CNV)

Who this might be right for
Myopic Choroidal Neovascularisation
AnewPharma 96
Large-scale testing (Phase 3)Study completedNCT01249664
What this trial is testing

VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)

Who this might be right for
Myopia, Pathological
Bayer 122
Not applicableStudy completedNCT02175940
What this trial is testing

VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularizationVEGF Aqueous LevelPEDF Aqueous Level
Università degli Studi di Brescia 40
Not applicableNot Yet RecruitingNCT07009574
What this trial is testing

The Treatment Burden of Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularisationAnti-VEGF TreatmentBurden
Policlinico Gaspare Rodolico - San Marco Catania 100
Not applicableStudy completedNCT05677685
What this trial is testing

VISUPRIME® Eye Drops

Who this might be right for
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more
VISUfarma SpA 78
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Large-scale testing (Phase 3)Study completedNCT01217944
What this trial is testing

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Pathological Myopia
Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)Study completedNCT01423149
What this trial is testing

Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Choroidal NeovascularizationMyopia, Degenerative
Mateon Therapeutics 23
Next Page